Science 37 Holdings Inc at Robert W Baird Global Healthcare Conference Transcript
Good afternoon, everyone. My name is Eric Coldwell. I cover pharma services for Baird, and it's our pleasure to have Science 37 with us this afternoon. I want to introduce David Coman, CEO; Mike Zaranek, CFO. We've known each other a while. We've known each other a long while; long history in the pharma services and related world.
Great pleasure to have the company with us today. I'm a lifetime CRO guy who has watched this slow inevitable transition to decentralized trial activity. And it's been really interesting, really fun -- cool might be the right word to watch the evolution of DCT specialists over the last few years.
And then what should prove to be a very big catalyst with COVID and how it's helping transition the world coupled with all the technology investments that have been made as well as capabilities to do trials in a more decentralized, flexible format.
I'm going to let our good friend Dave here just kick us off, go right into a presentation and then we'll jump in with Q&A. And really happy to have you with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |